对印度结核病诊断方法和治疗方法的成本效益进行系统审查
Mohan Balakrishnan1, R Varadharajan1, G Gajendran1
1Department of Mathematics, SRM Institute of Science and Technology, Kattankulathur-603203, Tamil Nadu, India.
The Indian journal of tuberculosis
|December 8, 2025
概括
评估印度的结核病诊断和治疗方法显示,公私合作伙伴关系与适当的诊断方法相结合是具有成本效益的. 需要进一步的研究,特别是从患者身上.
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
- 结核病研究 结核病研究
背景情况:
- 成本效益分析对于优化医疗干预和减少全球结核病负担至关重要.
- 了解结核病诊断和治疗的经济价值对于印度的资源配置至关重要.
研究的目的:
- 评估和确定印度实践的结核病诊断和治疗的成本效益.
- 综合印度结核病干预措施现有成本研究的发现.
主要方法:
- 对电子数据库 (PubMed,科学网,Scopus等) 的系统审查. 从1995年1月开始到2023年1月.
- 遵守系统审查 (PRISMA) 准则的优先报告项目.
- 使用共识健康经济标准检查清单对选定的研究进行质量评估.
主要成果:
- 在选出的12项研究中,有7项研究关注测试方法,5项研究关注治疗干预措施.
- 基于模型的成本分析主要利用从卫生系统的角度来看的状态过渡或决策树模型.
- 虽然唾液涂抹显微镜经常被超越,但涉及公私合作伙伴关系和适当的诊断方法的策略在结核病医疗保健中证明了成本效益.
结论:
- 印度对结核病干预措施的经济评估有限,特别是从患者的角度来看.
- 该研究提供了对结核病测试和治疗的经济评估的全面见解.
- 调查结果突出了实际应用和实施挑战,为开发改善的结核病控制战略和经济评估提供了信息.
相关概念视频
Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Pulmonary Tuberculosis I
806
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
806
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III
899
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
899
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182


